5-132312233-G-A
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_003059.3(SLC22A4):c.466G>A(p.Gly156Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,613,528 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003059.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC22A4 | ENST00000200652.4 | c.466G>A | p.Gly156Ser | missense_variant | Exon 2 of 10 | 1 | NM_003059.3 | ENSP00000200652.3 | ||
MIR3936HG | ENST00000621103.4 | n.845C>T | non_coding_transcript_exon_variant | Exon 8 of 8 | 1 | |||||
SLC22A4 | ENST00000491257.1 | n.270G>A | non_coding_transcript_exon_variant | Exon 2 of 4 | 4 | |||||
MIR3936HG | ENST00000669845.1 | n.471C>T | non_coding_transcript_exon_variant | Exon 4 of 4 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152152Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251432 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461376Hom.: 0 Cov.: 30 AF XY: 0.0000193 AC XY: 14AN XY: 727022 show subpopulations
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152152Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74328 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.466G>A (p.G156S) alteration is located in exon 2 (coding exon 2) of the SLC22A4 gene. This alteration results from a G to A substitution at nucleotide position 466, causing the glycine (G) at amino acid position 156 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 156 of the SLC22A4 protein (p.Gly156Ser). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with SLC22A4-related conditions. ClinVar contains an entry for this variant (Variation ID: 1910763). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SLC22A4 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at